Found 59 matching trials
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
PHASE2Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Location
Baylor College of Medicine
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
PHASE1A first in human study to evaluate the safety and preliminary antitumor act...
Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
PHASE2Surgical resection is the only potentially curative treatment for patients ...
Location
Smilow Cancer Hospital
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
PHASE2This is a phase II, multicenter, double-blinded, randomized, 2-arm trial ev...
Location
Mayo Clinic-Arizona
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer
PHASE1Pancreatic cancer is difficult to diagnose early. By the time people have b...
Status
Active Not Recruiting
Location
Virginia Mason Medical Center
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
PHASE1The investigators hypothesize that MK2 inhibition may improve efficacy of m...
Location
Washington University School of Medicine
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)
PHASE3The main aim of this study is to compare the efficacy of short-course versu...
Status
Active Not Recruiting
Location
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
PHASE1This is an open-label, phase 1/2, multiple-indication platform study to exp...
Status
Active Not Recruiting
Location
Nationales Centrum für Tumorerkrankungen Heidelberg
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
PHASE1This study is a prospective, single-arm, multicenter, phase Ib/II clinical ...
Location
First Affiliated Hospital of Fujian Medical University
SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
PHASE2A randomized phase II study to compare the efficacy and safety of SLOG or m...
Location
National Institute of Cancer Research